Similar articles

• Evaluation of calcium urolithiasis in ambulatory patients: comparison of results with those of inpatient evaluation.

  Pak CY, Fetner C, Townsend J, Brinkley L, Northcutt C, Barilla DE, Kadesky M, Peters P. Pak CY, et al. Am J Med. 1978 Jun;64(6):979-87. doi: 10.1016/0002-9343(78)90453-9. Am J Med. 1978. PMID: 207183 No abstract available.
• [The significance of uric acid in calcium oxalate nephrolithiasis].

  Hartung R. Hartung R. MMW Munch Med Wochenschr. 1975 Mar 7;117(10):387-90. MMW Munch Med Wochenschr. 1975. PMID: 804601 German.
• Metabolic basis of renal-stone disease.

  Broadus AE, Thier SO. Broadus AE, et al. N Engl J Med. 1979 Apr 12;300(15):839-45. doi: 10.1056/NEJM197904123001507. N Engl J Med. 1979. PMID: 34098 No abstract available.
• [Hypercalciuria, primary hyperparathyroidism and calcium nephrolithiasis].

  Ivanov I. Ivanov I. Vutr Boles. 1984;23(2):1-7. Vutr Boles. 1984. PMID: 6331011 Review. Bulgarian. No abstract available.
• Endocrine aspects of nephrolithiasis.

  Breslau NA, Pak CY. Breslau NA, et al. Spec Top Endocrinol Metab. 1982;3:57-86. Spec Top Endocrinol Metab. 1982. PMID: 6302932 Review. No abstract available.